A diagram of the DRT3 system, showing Drt3a in yellow and Drt3b in blue. (Hyunbin Lee) Scientists have just discovered an ...

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...

Researchers from the University of Birmingham have been awarded project grants to investigate weaknesses in cancers which could lead to new treatments.

Although the genetic material of most living organisms is DNA, various self-replicating agents rely instead on RNA, including ...

A new method developed at Baylor College of Medicine and collaborating institutions allows researchers to better understand ...